Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check2 days agoChange DetectedThe page revision has been updated to v3.3.4. The previous revision was v3.3.3.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations section updated to include New York as a study site (White Plains, NY). Revision: v3.3.3.SummaryDifference0.2%

- Check51 days agoChange DetectedTwo minor textual updates were made: a note about publications being provided voluntarily and a revision tag (Revision: v3.3.2) were added, which do not affect core study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoval of the government funding/operating-status notice from the page. No core study content, eligibility criteria, outcomes, or locations were altered.SummaryDifference0.4%

- Check73 days agoChange DetectedA Study Results section with published trial results and related publications has been added to the page. This includes outcomes and methodologies from the Benfotiamine in Alzheimer’s Disease study.SummaryDifference0.4%

- Check102 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.